PuSH - Publikationsserver des Helmholtz Zentrums München

Jeske, S. ; Wettengel, J.M. ; Gegenfurtner, F. ; Fischer, K.* ; Moosmüller, J. ; Chakraborty, A. ; Ko, C. ; Burwitz, B.J.* ; Schnieke, A.* ; Protzer, U.

Identification of amino acids restricting HBV receptor function in porcine NTCP.

Npj Viruses 2:30 (2024)
Verlagsversion DOI PMC
Free journal
Creative Commons Lizenzvertrag
With 254 million chronically infected patients, hepatitis B virus (HBV) continues to be a severe health threat. While animal models play a crucial role in developing new therapies, the availability of preclinical HBV models is very limited. Therefore, novel in vivo infection models are urgently needed. The bona fide HBV receptor, sodium-taurocholate cotransporting polypeptide (NTCP), determines HBV's species and cell-type specificity. Recent studies have indicated that the expression of human NTCP is the only limiting factor for HBV infection in selected species, such as macaques or pigs. Here, we confirm HBV infection of pig hepatocytes expressing human NTCP and show that porcine NTCP does not support HBV binding. By gradually humanizing porcine NTCP and site-directed mutagenesis, we identified amino acids 158 and 167 in porcine NTCP, limiting HBV interaction. In a proof-of-concept experiment, we showed that the expression of porcine NTCP with humanized amino acids 157-167 renders primary porcine hepatocytes fully susceptible to HBV. These results pave the way for generating transgenic pigs with humanized porcine chimeric NTCP as a novel, fully immunocompetent infection model for developing and validating new curative HBV therapies.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.000
0.000
2
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 2948-1767
e-ISSN 2948-1767
Zeitschrift Npj Viruses
Quellenangaben Band: 2, Heft: 1, Seiten: , Artikelnummer: 30 Supplement: ,
Verlag Springer
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-003
G-502799-701
Scopus ID 105022277772
PubMed ID 40295677
Erfassungsdatum 2025-05-11